Assertion: placebo's study | /r/HasProperty | patient
Facets:
value: with moderate renal impairment
type: OTHER
Source sentences:
text: (12.3)]. The safety and efficacy of Victoza was evaluated in a 26-week clinical study that included patients with moderate renal impairment (eGFR 30 to 60 mL/min/1.73m2) [see Clinical Studies (14.1)].